$GTHX G1 Therapeutics, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in G1 Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in G1 Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in G1 Therapeutics, Inc. for free.
IRS Number: 263648180
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: GTHX
Company Address: 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK 27709
Phone number: 919-213-9835
Former name: G-Zero Therapeutics, Inc., date of change: 2012-10-12
G1 Therapeutics, Inc. engages in the development of small molecule therapeutics for the treatment of patients with cancer. Its products pipeline includes trilaciclib, rintodestrant, and lerociclib. The company was founded by Kwok-Kin Wong and Norman E. Sharpless on May 19, 2008 and is headquartered in Research Triangle Park, NC.
G1 Therapeutics, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Option Exercise | M | 0.39 | 10,000 | 3,900 | 307,286 | ||
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Option Exercise | M | 0.39 | 10,000 | 3,900 | 307,286 | ||
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Option Exercise | M | 0.39 | 10,000 | 3,900 | 317,286 | ||
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Option Exercise | M | 0.39 | 10,000 | 3,900 | 317,286 | ||
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Option Exercise | M | 0.39 | 10,000 | 3,900 | 327,286 | ||
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Option Exercise | M | 0.39 | 10,000 | 3,900 | 327,286 | ||
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Sell | S | 20.54 | 10,000 | 205,413 | 41,000 | 51 K to 41 K (-19.61 %) | |
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Sell | S | 20.54 | 10,000 | 205,413 | 41,000 | 51 K to 41 K (-19.61 %) | |
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Buy | M | 0.39 | 10,000 | 3,900 | 51,000 | 41 K to 51 K (+24.39 %) | |
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Buy | M | 0.39 | 10,000 | 3,900 | 51,000 | 41 K to 51 K (+24.39 %) | |
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Sell | S | 20.07 | 10,000 | 200,691 | 41,000 | 51 K to 41 K (-19.61 %) | |
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Sell | S | 20.07 | 10,000 | 200,691 | 41,000 | 51 K to 41 K (-19.61 %) | |
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Buy | M | 0.39 | 10,000 | 3,900 | 51,000 | 41 K to 51 K (+24.39 %) | |
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Buy | M | 0.39 | 10,000 | 3,900 | 51,000 | 41 K to 51 K (+24.39 %) | |
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Sell | S | 19.10 | 10,000 | 190,997 | 41,000 | 51 K to 41 K (-19.61 %) |